LEXARIA BIOSCIENCE CORP. Number of Reportable Segments
LEXARIA BIOSCIENCE CORP. (LEXX) reported Number of Reportable Segments of 2 Segment for the 12-month period ending 2020-08-31, per its 10-K filed 2020-10-15.
Discontinued › Notes
us-gaap:NumberOfReportableSegments · last filed 2020-10-15
- LEXARIA BIOSCIENCE CORP. number of reportable segments for the quarter ending 2019-11-30 was 200.00%.
pure
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month |
|---|---|---|---|
| 2020-05-31 | 200.00% 10-Q · filed 2020-06-29 | ||
| 2020-02-29 | 200.00% 10-Q · filed 2020-04-03 | ||
| 2019-11-30 | 200.00% 10-Q · filed 2020-01-09 | ||
| 2019-05-31 | 200.00% 10-Q · filed 2019-07-08 |
Reportable_Segments
| Period end | Number of Reportable Segments 12 month |
|---|---|
| 2019-08-31 | 2.00 Reportable_Segments 10-K · filed 2019-11-14 |
Segment
| Period end | Number of Reportable Segments 12 month |
|---|---|
| 2020-08-31 | 2.00 Segment 10-K · filed 2020-10-15 |
| 2018-08-31 | 2.00 Segment 10-K · filed 2018-11-14 |
segment
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month |
|---|---|---|
| 2019-02-28 | 2.00 segment 10-Q · filed 2019-04-15 | |
| 2018-11-30 | 2.00 segment 10-Q · filed 2019-01-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |